After renal transplant the commonest malignancy is –
**Core Concept**
The development of malignancies in renal transplant patients is a significant concern due to the immunosuppressed state. This increased risk is attributed to the chronic use of immunosuppressive drugs, which impair the body's ability to mount an effective immune response against cancer cells.
**Why the Correct Answer is Right**
The most common malignancy in renal transplant patients is skin cancer, specifically squamous cell carcinoma (SCC). This is due to the prolonged exposure to ultraviolet (UV) radiation, which is a known risk factor for SCC. The immunosuppressed state of these patients further increases their susceptibility to UV-induced DNA damage, leading to the development of SCC. The use of immunosuppressive drugs such as cyclosporine and tacrolimus also contributes to the increased risk of skin cancer in renal transplant patients.
**Why Each Wrong Option is Incorrect**
* **Option A:** Although lymphomas are a significant concern in immunosuppressed patients, they are not the most common malignancy in renal transplant patients.
* **Option B:** Kaposi's sarcoma is a type of skin cancer that is more common in HIV/AIDS patients, but it is not the most common malignancy in renal transplant patients.
* **Option C:** Hepatocellular carcinoma is a type of liver cancer that is more common in patients with chronic liver disease, but it is not the most common malignancy in renal transplant patients.
**Clinical Pearl / High-Yield Fact**
Renal transplant patients are at increased risk of skin cancer due to prolonged exposure to UV radiation and immunosuppression. Regular skin examinations and sun protection measures are essential to prevent and detect skin cancer in these patients.
**Correct Answer: D. Squamous cell carcinoma.**